STAT3 and prostate carcinoma: On the basis of literature data, together with our results from previous studies on prostate cancer FFPE tissues [28], it is conceivable to hypothesize that STAT3 and its PTMs (which are observable in different PCa clinical stages, as measured by Gleason score grading) may be involved in the progression of PCa into a more aggressive form.